COMMUNIQUÉS West-GlobeNewswire

Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and Update

06/03/2018 - 22:01

EDIT-101 for Leber Congenital Amaurosis type 10 (LCA10) on track for mid-2018 Investigational New Drug (IND) filing Expecting at least five clinical-stage programs by end of 2022 as part of EM22 five-year goals Year-end [...]

Nuvectra™ Reports Fourth Quarter and Full Year 2017 Financial Results

06/03/2018 - 22:01

PLANO, Texas, March 06, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, today announced financial results for the fourth quarter and full year ended December 31 [...]

Optinose to Report Fourth Quarter and Full Year 2017 Financial Results and Corporate Updates on March 13, 2018

06/03/2018 - 22:01

YARDLEY, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will [...]

Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results

06/03/2018 - 22:01

ZX008 Granted Breakthrough Therapy Designation in Dravet syndrome by FDA Last patient randomized into second Phase 3 clinical trial of ZX008 in patients with Dravet syndrome, Study 1504 Initiated global Phase 3 clinical [...]

Adverum Biotechnologies Reports Fourth Quarter 2017 Financial Results and Provides Corporate Update

06/03/2018 - 22:00

MENLO PARK, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today [...]

Align Technology to Host Investor Day on May 23, 2018

06/03/2018 - 22:00

SAN JOSE, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN ) today announced that it will host an Investor Day on Wednesday, May 23, 2018, at the Park Central Hotel in New York City. [...]

T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update

06/03/2018 - 22:00

LEXINGTON, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]

Media Advisory: Theratechnologies to Hold a Conference Call Today

06/03/2018 - 20:49

MONTREAL, March 06, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ( Theratechnologies ) (TSX: TH ) and its partner TaiMed Biologics, Inc. (TaiMed) today announced that the U.S. Food and Drug Administration (FDA) has [...]

Avis aux médias : Theratechnologies tiendra un appel conférence aujourd’hui

06/03/2018 - 20:49

MONTRÉAL, 06 mars 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH ) et son partenaire TaiMed Biologics, Inc. (TaiMed) ont annoncé aujourd’hui que la Food and Drug Administration (FDA) aux [...]

Anthera Pharmaceuticals Deemed Compliant with Nasdaq Listing Criteria

06/03/2018 - 20:45

HAYWARD, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals (Nasdaq: ANTH ) today announced that Anthera has received formal notice from The NASDAQ Stock Market LLC (“Nasdaq”) indicating that the Company [...]

GIAPREZA™ (angiotensin II) Significantly Improved Survival and Reduced Time on Renal Replacement Therapy in Patients with Acute Kidney Injury

06/03/2018 - 20:40

Analyses to Be Presented in Oral and Poster Sessions at The 23rd International Conference on Advances in Critical Care Nephrology AKI & CRRT 2018 Manuscript Published Online in Critical Care Medicine SAN DIEGO, [...]

Adamas to Present at Two Upcoming Investor Conferences

06/03/2018 - 20:35

EMERYVILLE, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that company management is scheduled to present at two upcoming investor conferences: Gregory T. Went, [...]

Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo™ (ibalizumab-uiyk) Injection, the First HIV-1 Inhibitor and Long-Acting Monoclonal Antibody for Multidrug Resistant HIV-1

06/03/2018 - 20:15

First HIV treatment approved with a new mechanism of action in more than 10 years Infused every two weeks, only antiretroviral treatment (ART) that does not require daily dosing Trogarzo™ has no drug-drug interactions [...]

Cognition Therapeutics Co-Founder and CSO Susan Catalano to Present at the Annual ASENT Meeting

06/03/2018 - 20:04

Pittsburgh, March 06, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and [...]

UBM Americas launches Cannabis Science and Technology as part of Life Sciences portfolio

06/03/2018 - 19:33

ISELIN, N.J., March 06, 2018 (GLOBE NEWSWIRE) -- UBM Americas’ Life Sciences Group today announced the launch of Cannabis Science and Technology , a professional journal and website produced in alliance with the [...]

WishBone Medical, Inc. entered into a U.S. distribution agreement with Implanet

06/03/2018 - 19:16

WARSAW, Ind., March 06, 2018 (GLOBE NEWSWIRE) -- WishBone Medical. Inc. entered into a U.S. distribution agreement with Implanet to distribute the JAZZ implant system to treat spinal pathologies requiring vertebral [...]

Eloxx Pharmaceuticals To Present at the Cowen and Company 38th Annual Health Care Conference

06/03/2018 - 19:00

WALTHAM, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”), (ELOX) a clinical-stage biopharmaceutical company developing novel read-through drug candidates that are designed to treat rare [...]

Genesis HealthCare Closes on Previously Announced Financing Commitments

06/03/2018 - 17:05

KENNETT SQUARE, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE: GEN ) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced it has closed on its previously [...]

Virbac : Declaration of the number of shares and voting rights as of February 2018, 28.

06/03/2018 - 16:31

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]